What sector does Medplus Health Serv Ltd belong to?

Medplus Health Serv Ltd operates in the Consumer Discretionary sector, specifically the Pharmacy Retail industry, and is listed on the NSE.

What is the current share price of MEDPLUS?

As of the latest available quote, MEDPLUS traded at ₹660.15. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of MEDPLUS?

Medplus Health Serv Ltd has a price-to-earnings (P/E) ratio of about 37.74. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of MEDPLUS?

The market capitalisation of Medplus Health Serv Ltd is approximately ₹7,931 Cr.

Is Medplus Health Serv Ltd profitable?

For its latest reported financial year, Medplus Health Serv Ltd recorded a net profit margin of about 3.19%.

Does MEDPLUS pay a dividend?

Medplus Health Serv Ltd does not currently show a dividend yield in our data.

What is the return on equity (ROE) of MEDPLUS?

Medplus Health Serv Ltd has a return on equity (ROE) of about 11.60%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of MEDPLUS?

Over the past 52 weeks, MEDPLUS has traded between a low of ₹648.00 and a high of ₹1,022.20.

Medplus Health Serv Ltd

MEDPLUS NSE Consumer Discretionary Pharmacy Retail

Microcap 250

₹660.15

+0.32%

Delayed · cached 15 min

Fair value analysis

MEDPLUS

Medplus Health Serv Ltd

₹658.05

Close used for this calculation

₹726.64Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

51/100

Profitability17/25

Returns12/25

Balance Sheet14/25

Efficiency8/25

Growth17/25

Good

Quality radar

Consensus fair value

₹726.64

Near FV

▲ +10.4% against the close used

Model range ₹220.40 – ₹1,212.55

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹220.40Fair value₹726.64Bull₹1,212.55

FairClose

52-week traded range

52W low ₹649.3052W high ₹953.90

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading close to the consensus fair value

Medplus Health Serv Ltd closed at ₹658.05, 9.4% below the consensus fair value of ₹726.64 drawn from 9 valuation models.

Financial DNA score 51/100 — Good. P/E of 37.7x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹614.30

-6.6%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=9%, r=10%, tg=3%, n=10yr

Graham Number

₹254.60

-61.3%

√(22.5 × EPS × BVPS)

EPS=18.3, BVPS=157.43 · outside Graham range (P/E 37.7, P/B 4.2) — asset-light, treat as a rough floor

Graham Formula

₹824.15

+25.2%

EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate

g=20%, FD=7%

P/E Fair Value

₹904.94

+37.5%

EPS × 49.45x (sector P/E)

EPS=18.3, Sector P/E=49.45x

Peter Lynch (PEG)

₹457.50

-30.5%

EPS × Growth% (PEG = 1 is fair)

EPS=18.3, g=25%

EV/EBITDA

₹1,212.55

+84.3%

(EBITDA × 18x − Net Debt) ÷ Shares

EBITDA=8.91B

Book Value (P/B)

₹220.40

-66.5%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=157.43, ROE=11.6%, g=6%, r=10%

Reverse DCF

₹658.05

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 15.1% | Historical: 25%

Margin of Safety

₹487.12

-26.0%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=649.5, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer